After the studies outlined above identified the roles of CXCL13 and CXCR5 in the development of differentiated B-cells and their secondary lymphoid structures, it was natural to hypothesize that aberrant activation of this signaling axis contributes to autoimmune conditions. This evidence concerns the gene CXCR5 and Autoimmunity.